Daré Bioscience, Inc.DARENASDAQ
Loading
Year-over-year net income growth rate
Percentile
P59
Within normal range
vs 2Y Ago
2.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 11.30% |
| Q2 2025 | 8.26% |
| Q1 2025 | 20.49% |
| Q4 2024 | -17.10% |
| Q3 2024 | -136.42% |
| Q2 2024 | 291.12% |
| Q1 2024 | -33.57% |
| Q4 2023 | 39.06% |
| Q3 2023 | 5.29% |
| Q2 2023 | -8.95% |
| Q1 2023 | 49.56% |
| Q4 2022 | -127.12% |
| Q3 2022 | -1795.62% |
| Q2 2022 | 104.93% |
| Q1 2022 | 11.98% |
| Q4 2021 | 24.67% |
| Q3 2021 | -38.25% |
| Q2 2021 | -25.11% |
| Q1 2021 | 13.24% |
| Q4 2020 | -11.32% |
| Q3 2020 | -6.44% |
| Q2 2020 | -67.54% |
| Q1 2020 | -9.98% |
| Q4 2019 | -13.95% |
| Q3 2019 | 14.14% |
| Q2 2019 | -29.49% |
| Q1 2019 | -4.63% |
| Q4 2018 | -13.33% |
| Q3 2018 | 28.14% |
| Q2 2018 | 53.27% |
| Q1 2018 | 16.04% |
| Q4 2017 | -460.18% |
| Q3 2017 | 60.58% |
| Q2 2017 | 34.77% |
| Q1 2017 | -28.19% |
| Q4 2016 | 50.35% |
| Q3 2016 | 8.29% |
| Q2 2016 | 19.81% |
| Q1 2016 | -26.47% |
| Q4 2015 | -1.49% |